Candriam Equities L Oncology Impact I/ LU1864482358 /
| NAV2024-05-08 | Chg.-14.0498 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 2,805.0901USD | -0.50% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018 | - | - | - | - | - | - | - | - | - | - | - | -6.00 | - |
| 2019 | 10.25 | 6.19 | 2.66 | -3.64 | -2.56 | 8.69 | 0.30 | -0.28 | -3.18 | 5.10 | 7.96 | 5.03 | +41.52% |
| 2020 | -1.46 | -5.35 | -3.07 | 12.12 | 8.54 | 1.42 | 4.43 | 2.15 | 3.52 | -2.21 | 5.82 | 3.86 | +32.43% |
| 2021 | 0.55 | -4.20 | -0.09 | 2.33 | 0.17 | 3.53 | -0.96 | 5.58 | -3.77 | 3.37 | -6.37 | 3.99 | +3.43% |
| 2022 | -10.49 | -1.75 | 4.65 | -5.85 | -1.33 | 0.04 | 4.37 | -3.14 | -4.71 | 7.04 | 6.07 | -3.44 | -9.67% |
| 2023 | 2.16 | -3.88 | 1.38 | 2.83 | -2.56 | 0.08 | 0.89 | -2.02 | -5.25 | -6.36 | 9.21 | 5.73 | +1.11% |
| 2024 | 1.37 | 4.14 | 1.49 | -3.38 | 2.13 | - | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 11.01% | 11.48% | 11.75% | 14.75% | 17.31% |
| Sharpe ratio | 1.23 | 2.95 | -0.06 | -0.18 | 0.36 |
| Best month | +5.73% | +9.21% | +9.21% | +9.21% | +12.12% |
| Worst month | -3.38% | -3.38% | -6.36% | -10.49% | -10.49% |
| Maximum loss | -6.77% | -6.77% | -16.08% | -25.08% | -25.08% |
| Outperformance | +19.13% | - | +25.64% | - | - |
All quotes in USD
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Oncology Imp... | reinvestment | 2,334.9299 | +3.50% | +4.38% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,494.9299 | +3.63% | +4.77% | |
| Candriam Equities L Oncology Imp... | reinvestment | 202.4300 | +0.03% | -6.34% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,221.3799 | +4.29% | +17.03% | |
| Candriam Equities L Oncology Imp... | paying dividend | 1,567.1400 | +3.17% | +3.38% | |
| Candriam Equities L Oncology Imp... | reinvestment | 241.4500 | +4.71% | +13.69% | |
| Candriam Equities L Oncology Imp... | paying dividend | 229.8600 | +2.20% | +0.52% | |
| Candriam Equities L Oncology Imp... | paying dividend | 186.0900 | +3.07% | +3.08% | |
| Candriam Equities L Oncology Imp... | paying dividend | 20,310.0000 | +0.06% | +1.20% | |
| Candriam Equities L Oncology Imp... | reinvestment | 157.1600 | +4.18% | +16.63% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,057.6101 | +0.98% | -3.66% | |
| Candriam Equities L Oncology Imp... | reinvestment | 255.7700 | +5.60% | +16.60% | |
| Candriam Equities L Oncology Imp... | reinvestment | 201.9600 | -0.37% | -7.43% | |
| Candriam Equities L Oncology Imp... | reinvestment | 279.0300 | +3.06% | +3.07% | |
| Candriam Equities L Oncology Imp... | reinvestment | 188.9900 | +0.87% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 1,832.0800 | +4.63% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,805.0901 | +3.17% | +3.38% | |
| Candriam Equities L Oncology Imp... | reinvestment | 155.2600 | - | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 267.0600 | +2.20% | +0.51% |
Performance
| YTD | +5.72% | ||
|---|---|---|---|
| 6 Months | +17.19% | ||
| 1 Year | +3.17% | ||
| 3 Years | +3.38% | ||
| 5 Years | +61.00% | ||
| 10 Years | - | ||
| Since start | +87.01% | ||
| Year | |||
| 2023 | +1.11% | ||
| 2022 | -9.67% | ||
| 2021 | +3.43% | ||
| 2020 | +32.43% | ||
| 2019 | +41.52% | ||
